前列腺癌：I期研究显示TRC105在转移性去势抵抗性前列腺癌（mCRPC）中的潜力。 - Suppr

Prostate cancer: Phase I study shows potential of TRC105 in mCRPC.

作者信息

Kelsey Rebecca

出版信息

Nat Rev Urol. 2015 Jan;12(1):6. doi: 10.1038/nrurol.2014.336. Epub 2014 Dec 9.

DOI:10.1038/nrurol.2014.336

PMID:25487051

Abstract

摘要

相似文献

Prostate cancer: Phase I study shows potential of TRC105 in mCRPC.

Nat Rev Urol. 2015 Jan;12(1):6. doi: 10.1038/nrurol.2014.336. Epub 2014 Dec 9.

Is angiogenesis still an attractive target in metastatic castration-resistant prostate cancer?

BJU Int. 2015 Oct;116(4):500-1. doi: 10.1111/bju.13070.

A Novel Use of Olaparib for the Treatment of Metastatic Castration-Recurrent Prostate Cancer.

Pharmacotherapy. 2017 Nov;37(11):1406-1414. doi: 10.1002/phar.2027.

A Case of Locally Advanced Castration-resistant Prostate Cancer With Remarkable Response to Nivolumab.

Clin Genitourin Cancer. 2017 Oct;15(5):e881-e884. doi: 10.1016/j.clgc.2017.05.005. Epub 2017 May 24.

Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study.

Eur Urol. 2016 May;69(5):834-40. doi: 10.1016/j.eururo.2015.09.046. Epub 2015 Oct 17.

Prostate cancer: Clinical implications of therapeutic sequence in mCRPC.

Nat Rev Urol. 2015 Jan;12(1):13-4. doi: 10.1038/nrurol.2014.308. Epub 2014 Nov 18.

Prospects for the use of ipilimumab in treating advanced prostate cancer.

Expert Opin Biol Ther. 2016;16(3):421-32. doi: 10.1517/14712598.2016.1136284. Epub 2016 Jan 25.

Effectiveness and tolerability of targeted drugs for the treatment of metastatic castration-resistant prostate cancer: a network meta-analysis of randomized controlled trials.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1751-1768. doi: 10.1007/s00432-018-2664-y. Epub 2018 May 24.

Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?

BJU Int. 2015 Mar;115(3):364-72. doi: 10.1111/bju.12736. Epub 2014 Jul 15.

Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.

Eur Urol. 2017 Apr;71(4):656-664. doi: 10.1016/j.eururo.2016.06.033. Epub 2016 Jul 9.

引用本文的文献

Endoglin in the Spotlight to Treat Cancer.

Int J Mol Sci. 2021 Mar 20;22(6):3186. doi: 10.3390/ijms22063186.

Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'?

Target Oncol. 2016 Aug;11(4):431-46. doi: 10.1007/s11523-015-0412-7.

本文引用的文献

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.

BJU Int. 2015 Oct;116(4):546-55. doi: 10.1111/bju.12986. Epub 2015 Jun 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Prostate cancer: Phase I study shows potential of TRC105 in mCRPC.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献